Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 3,373 | 3,516 | 4,001 | 2,842 | 2,929 |
| Cost of Goods | 653 | 444 | 515 | 291 | 370 |
| Gross Profit | 2,720 | 3,072 | 3,486 | 2,551 | 2,559 |
| Operating Expenses | 24,038 | 20,445 | 20,353 | 21,888 | 22,248 |
| Operating Income | -20,665 | -16,929 | -16,352 | -19,046 | -19,319 |
| Interest Expense | 855 | 574 | 564 | 561 | 546 |
| Other Income | 235 | 439 | 537 | 275 | 342 |
| Pre-tax Income | -21,285 | -17,064 | -16,379 | -19,332 | -19,523 |
| Net Income Continuous | -21,285 | -17,064 | -16,379 | -19,332 | -19,523 |
| Net Income | $-21,285 | $-17,064 | $-16,379 | $-19,332 | $-19,523 |
| EPS Basic Total Ops | -0.74 | -0.60 | -0.58 | -0.69 | -0.69 |
| EPS Basic Continuous Ops | -0.74 | -0.60 | -0.58 | -0.69 | -0.69 |
| EPS Diluted Total Ops | -0.74 | -0.60 | -0.58 | -0.69 | -0.69 |
| EPS Diluted Continuous Ops | -0.74 | -0.60 | -0.58 | -0.69 | -0.69 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.60 | -0.58 | -0.69 | -0.69 |
| EBITDA(a) | $-20,347 | $-16,705 | $-16,100 | $-18,803 | $-19,081 |